• Je něco špatně v tomto záznamu ?

Association of α-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain

PH. Horta-López, G. Mendoza-Franco, F. Rodríguez-Cruz, FM. Torres-Cruz, E. Hernández-Echeagaray, JJ. Jarero-Basulto, J. Rícny, B. Florán Garduño, F. Garcia-Sierra

. 2023 ; 518 (-) : 83-100. [pub] 20220108

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc23011461

In Alzheimer's disease (AD), two mutually exclusive amino-terminal-dependent conformations have been reported to occur during the aggregation of Tau protein into neurofibrillary tangles (NFTs). An early conformation of full-length Tau, involving the bending of the amino terminus over the third repeated domain, is recognized by the Alz-50 antibody, followed by a second conformation recognized by Tau-66 antibody that depends on the folding of the proline-rich region over the third repeated domain in a molecule partially truncated at the amino- and carboxyl-termini. α-1-antichymotrypsin (ACT) is an acute phase serum glycoprotein that accumulates abnormally in the brain of AD patients, and since it is considered to promote the in vitro and in vivo aggregation of amyloid-β, we here seek further evidence that ACT may also contribute to the abnormal aggregation of Tau in AD. By analyzing brain samples from a population of AD cases under immunofluorescence and high-resolution confocal microscopy, we demonstrate here the abundant expression of ACT in hippocampal neurons, visualized as a granular diffuse accumulation, frequently reaching the nuclear compartment. In a significant number of these neurons, intracellular NFTs composed of abnormally phosphorylated and truncated Tau at Asp421 were also observed to coexist in separated regions of the cytoplasm. However, we found strong colocalization between ACT and diffuse aggregates of Tau-66-positive granules, which was not observed with Alz-50 antibody. These results suggest that ACT may play a role during the development of Tau conformational changes facilitating its aggregation during the formation of the neurofibrillary pathology in AD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23011461
003      
CZ-PrNML
005      
20230801133047.0
007      
ta
008      
230718s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.neuroscience.2022.01.002 $2 doi
035    __
$a (PubMed)35007692
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Horta-López, Perla H $u Department of Physiology, Biophysics and Neurosciences, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico
245    10
$a Association of α-1-Antichymotrypsin Expression with the Development of Conformational Changes of Tau Protein in Alzheimer's Disease Brain / $c PH. Horta-López, G. Mendoza-Franco, F. Rodríguez-Cruz, FM. Torres-Cruz, E. Hernández-Echeagaray, JJ. Jarero-Basulto, J. Rícny, B. Florán Garduño, F. Garcia-Sierra
520    9_
$a In Alzheimer's disease (AD), two mutually exclusive amino-terminal-dependent conformations have been reported to occur during the aggregation of Tau protein into neurofibrillary tangles (NFTs). An early conformation of full-length Tau, involving the bending of the amino terminus over the third repeated domain, is recognized by the Alz-50 antibody, followed by a second conformation recognized by Tau-66 antibody that depends on the folding of the proline-rich region over the third repeated domain in a molecule partially truncated at the amino- and carboxyl-termini. α-1-antichymotrypsin (ACT) is an acute phase serum glycoprotein that accumulates abnormally in the brain of AD patients, and since it is considered to promote the in vitro and in vivo aggregation of amyloid-β, we here seek further evidence that ACT may also contribute to the abnormal aggregation of Tau in AD. By analyzing brain samples from a population of AD cases under immunofluorescence and high-resolution confocal microscopy, we demonstrate here the abundant expression of ACT in hippocampal neurons, visualized as a granular diffuse accumulation, frequently reaching the nuclear compartment. In a significant number of these neurons, intracellular NFTs composed of abnormally phosphorylated and truncated Tau at Asp421 were also observed to coexist in separated regions of the cytoplasm. However, we found strong colocalization between ACT and diffuse aggregates of Tau-66-positive granules, which was not observed with Alz-50 antibody. These results suggest that ACT may play a role during the development of Tau conformational changes facilitating its aggregation during the formation of the neurofibrillary pathology in AD.
650    _2
$a lidé $7 D006801
650    12
$a Alzheimerova nemoc $x metabolismus $7 D000544
650    _2
$a proteiny tau $x metabolismus $7 D016875
650    _2
$a neurofibrilární klubka $x metabolismus $x patologie $7 D016874
650    _2
$a neurony $x metabolismus $7 D009474
650    _2
$a mozek $x metabolismus $7 D001921
650    _2
$a protilátky $7 D000906
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Mendoza-Franco, Graciela $u Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico
700    1_
$a Rodríguez-Cruz, Fanny $u Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico
700    1_
$a Torres-Cruz, Francisco M $u Laboratorio de Neurofisiología del Desarrollo y la Neurodegeneración, UBIMED, FES-Iztacala, Universidad Nacional Autónoma de México, Ciudad de México, Mexico
700    1_
$a Hernández-Echeagaray, Elizabeth $u Laboratorio de Neurofisiología del Desarrollo y la Neurodegeneración, UBIMED, FES-Iztacala, Universidad Nacional Autónoma de México, Ciudad de México, Mexico
700    1_
$a Jarero-Basulto, Jose J $u Cellular Neurobiology Laboratory, Cell and Molecular Biology Department, CUCBA, University of Guadalajara, Zapopan, Mexico
700    1_
$a Rícny, Jan $u National Institute of Mental Health, Klecany, Czech Republic
700    1_
$a Florán Garduño, Benjamín $u Department of Physiology, Biophysics and Neurosciences, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico. Electronic address: bfloran@fisio.cinvestav.mx
700    1_
$a Garcia-Sierra, Francisco $u Department of Cell Biology, Center for Research and Advanced Studies of the National Polytechnic Institute, Mexico City, Mexico. Electronic address: f.garcia.sierra@cinvestav.mx
773    0_
$w MED00003505 $t Neuroscience $x 1873-7544 $g Roč. 518, č. - (2023), s. 83-100
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35007692 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230718 $b ABA008
991    __
$a 20230801133044 $b ABA008
999    __
$a ok $b bmc $g 1963709 $s 1197726
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 518 $c - $d 83-100 $e 20220108 $i 1873-7544 $m Neuroscience $n Neuroscience $x MED00003505
LZP    __
$a Pubmed-20230718

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...